Trial NCT03694197

View at ClinicalTrials.gov 
Org. Study IDs: R727-CL-1609
Secondary IDs: 2018-002810-11

Last trial update was posted on 2021-06-15

MeSH Interventions

Alirocumab

MeSH Conditions

Hypercholesterolemia Hyperlipoproteinemia Type II

Other Conditions

Heterozygous Familial Hypercholesterolemia Non-familial Hypercholesterolemia

Stopping Reasons

The primary objective (to evaluate the long-term safety of Praluent) was adequately evaluated in other studies.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID